听力损失和阿尔茨海默氏症的疾病
Arianna Di Stadio1, Mickie J Hamiter2, Dalila Roccamatisi3
1GF Ingrassia Department, Otolaryngology, University of Catania, Catania, Italy.
Current topics in behavioral neurosciences
|October 22, 2024
概括
未经治疗的听力损失 (HL) 与认知能力下降有关,并增加了阿尔茨海默氏症.
科学领域:
- 神经科学是一个神经科学.
- 听力学 听力学是指听力学.
- 老年学是一门学科.
背景情况:
- 听力损失 (HL) 和认知能力下降经常同时存在.
- 新兴研究将未经治疗的HL与患有认知衰退的患者中阿尔茨海默病 (AD) 风险增加联系在一起.
研究的目的:
- 探索听力损失和认知功能之间的关系.
- 为了检查听力损失和阿尔茨海默病之间的特定联系.
- 审查听力损失的治疗方法及其认知影响.
主要方法:
- 对调查听力损失和认知研究的文献综述.
- 讨论中心与外周听力损失.
- 功能性MRI和EEG发现的分析.
主要成果:
- 未经治疗的听力损失会加剧认知能力的下降.
- 患阿尔茨海默病的风险更高与认知障碍患者未经治疗的听力损失有关.
结论:
- 了解听力损失和认知衰退之间的联系至关重要.
- 听力损失的治疗可能会对记忆和认知产生积极影响,可能减轻阿尔茨海默病的进展.
相关概念视频
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Hearing
51.9K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.9K
Role of Neurotransmitters in Memory
456
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
456
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Olfactory Receptors: Location and Structure
8.9K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
8.9K


